Literature DB >> 19466393

Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats.

Benoît Forget1, Michel Hamon, Marie-Hélène Thiébot.   

Abstract

RATIONALE: The noradrenergic system might be a critical mediator of psychostimulants and opiates hedonic value.
OBJECTIVES: The objective of this study is to evaluate the involvement of alpha1-adrenoceptors (alpha1-ARs) in nicotine incentive learning.
MATERIALS AND METHODS: Rats, subjected to an unbiased conditioned place preference (CPP) procedure, received eight 30-min alternating nicotine (0.06 mg/kg) and saline pairings with distinct floor textures. The alpha1-AR antagonist, prazosin (0.125, 0.25, 0.5, or 1 mg/kg), was administered 30 min before nicotine pairings (acquisition) or one of the two 20-min test sessions conducted 24 h and 3 weeks after conditioning (expression).
RESULTS: Pre-pairing injections of prazosin (0.5-1 mg/kg) prevented the acquisition of nicotine-CPP. On pre-test administration, prazosin (0.5 mg/kg) abolished the short-term expression of nicotine-CPP; whereas, none of the tested doses impaired its long-term expression. During a drug-free 3-week test session, nicotine-CPP was also weakened in rats given prazosin (0.5 mg/kg) before the 24-h test, while nicotine-CPP was reduced neither in animals given prazosin immediately after the first test session nor in those not subjected to the 24-h test.
CONCLUSIONS: The activation of alpha1-ARs is one of the mechanisms that code for the incentive motivational value of nicotine. It participates also in the short-term, but not the long-term, control of behavior by nicotine-paired stimuli. The latter effect does not result from disruption by prazosin of either memory for the nicotine-cue association or reconsolidation processes at recall. Thus, differences exist in the neurobiological mechanisms that contribute to the incentive motivational value of nicotine and the short- and long-term "memory" of the incentive salience acquired by nicotine-paired cues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466393     DOI: 10.1007/s00213-009-1559-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

1.  Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

Authors:  A J Grottick; G A Higgins
Journal:  Behav Brain Res       Date:  2000-12-20       Impact factor: 3.332

2.  Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine.

Authors:  Jesse R Schank; Rossella Ventura; Stefano Puglisi-Allegra; Antonio Alcaro; Charlene D Cole; L Cameron Liles; Philip Seeman; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2005-12-14       Impact factor: 7.853

Review 3.  Affective neuroscience of pleasure: reward in humans and animals.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

Review 4.  Molecular mechanisms of memory reconsolidation.

Authors:  Natalie C Tronson; Jane R Taylor
Journal:  Nat Rev Neurosci       Date:  2007-04       Impact factor: 34.870

5.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

6.  Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.

Authors:  W X Shi; C L Pun; X X Zhang; M D Jones; B S Bunney
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

7.  Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine.

Authors:  S N Mitchell
Journal:  Neuropharmacology       Date:  1993-10       Impact factor: 5.250

8.  Frequency-dependent modulation of dopamine release by nicotine.

Authors:  Hui Zhang; David Sulzer
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

9.  Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization.

Authors:  B M Sharp; S G Matta
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

10.  Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice.

Authors:  Mohammad-Reza Zarrindast; Taraneh Bahreini; Mohammad Adl
Journal:  Pharmacol Biochem Behav       Date:  2002-11       Impact factor: 3.533

View more
  11 in total

1.  Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.

Authors:  Patricia Di Ciano; Daniel F Manvich; Abhiram Pushparaj; Andrew Gappasov; Ellen J Hess; David Weinshenker; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2017-10-30       Impact factor: 4.530

2.  Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.

Authors:  Benoit Forget; Carrie Wertheim; Paola Mascia; Abhiram Pushparaj; Steven R Goldberg; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

3.  α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions.

Authors:  Abhiram Pushparaj; Yaroslaw Pryslawsky; Benoit Forget; Yijin Yan; Bernard Le Foll
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

5.  Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans.

Authors:  Bernard Le Foll; Mihail Guranda; Alan A Wilson; Sylvain Houle; Pablo M Rusjan; Victoria C Wing; Laurie Zawertailo; Usoa Busto; Peter Selby; Arthur L Brody; Tony P George; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2013-08-19       Impact factor: 7.853

6.  A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation.

Authors:  Sherry A McKee; Marc N Potenza; Hedy Kober; Mehmet Sofuoglu; Amy F T Arnsten; Marina R Picciotto; Andrea H Weinberger; Rebecca Ashare; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

Review 7.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

8.  Rhodiola rosea L. extract and its active compound salidroside antagonized both induction and reinstatement of nicotine place preference in mice.

Authors:  Federica Titomanlio; Marina Perfumi; Laura Mattioli
Journal:  Psychopharmacology (Berl)       Date:  2013-11-22       Impact factor: 4.530

9.  Pilot investigation of the effect of carvedilol on stress-precipitated smoking-lapse behavior.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Rebecca L Ashare; Brian P Pittman; Julia M Shi; Jeanette M Tetrault; Meaghan Lavery; Sherry A McKee
Journal:  J Psychopharmacol       Date:  2018-04-25       Impact factor: 4.153

10.  Rat ultrasonic vocalizations as an index of memory.

Authors:  Kyrie-Anne E Reyes; Priya S Kudva; Benjamin Heckler; Angela E Gonzalez; Barbara A Sorg
Journal:  Neurosci Lett       Date:  2020-11-06       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.